Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jul 2011

Dias-Santagata Dora, Lam Quynh, Bergethon Kristin, Baker Gabrielle M, Iafrate A John, Rakheja Dinesh, Hoang Mai P

Abstract excerpt

Metastasizing adnexal carcinomas are rare; thus, currently there is no uniform treatment guideline. Chemotherapeutic drugs that selectively target cancer-promoting pathways may complement conventional therapeutic approaches. We performed immunohistochemistry (epidermal growth factor receptor (EGFR), HER2, and CD117), EGFR and ERBB2 fluorescence in situ hybridization (FISH), and multiplexed SNaPshot® genotyping...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Delivery Systems

Share to Neoplasm Metastasis

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins c-kit

Share to ras Proteins

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 21423156
DOI: 10.1038/modpathol.2011.48

Genes

EGFR
ERBB2
BRAF
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.PMID 21423156Read ↗

Identification of potentially druggable molecular alterations in skin adnexal malignanciesSemantic proximity Read ↗

When the Skin Tells a Bigger Story: Distinguishing Cutaneous Metastases from Primary Adnexal Carcinomas in DermatopathologySemantic proximity Read ↗

Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma.Semantic proximity Read ↗

Metastatic Microcystic Adnexal Carcinoma with DNA Sequencing Results and Response to Systemic Antineoplastic Chemotherapy.Semantic proximity Read ↗

Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition.Semantic proximity Read ↗

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humansSemantic proximity Read ↗

A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation.Semantic proximity Read ↗

Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.Semantic proximity Read ↗

What is new in adnexal tumors of the skin?Semantic proximity Read ↗

Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinomaSemantic proximity Read ↗

GATA3 and MYB Expression in Cutaneous Adnexal NeoplasmsSemantic proximity Read ↗

Everolimus plus anastrozole for female adnexal tumor of probable Wolffian origin (FATWO) with STK11 mutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.